China Biopharm Registers High Growth Figures For First Quarter
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China Biopharmaceuticals saw a strong growth in revenues in the first quarter of 2008 on the back of increased sales from its subsidiary Erye Pharmaceuticals. The company released fiscal results for its first quarter ended March 31 on May 16